EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation

Yuandi Huang, Dexi Su, Jinshan You, Yu Zhang, Zeyu Li, Hao Liu, Qiang Fang, Yi Zhi iD, Weibing Li

Journal of Inflammation Research · 2026-02 · Volume 19 · 1-18

DOI: 10.2147/jir.s574702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-02. Verfasst von Yuandi Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, People's Republic of China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to investigate the protective effects and underlying mechanisms of ginsenoside Rg1 in renal ischemia-reperfusion injury, with a focus on oxidative stress, macrophage polarization, and prevention of early profibrotic responses.

Methods

An in vivo mouse renal IRI model and an in vitro oxygen-glucose deprivation/reperfusion (OGD/R) model using RAW264.7 macrophages were employed to evaluate renal function, oxidative stress, macrophage polarization, pro-inflammatory cytokine expression, and activation of the STING-NF-κB signaling pathway.

Results

Rg1 alleviated renal tubular injury, preserved renal function, and reduced oxidative stress and tubular apoptosis in IRI mice. It also inhibited systemic leukocyte activation and local inflammatory cell infiltration. In vitro, Rg1 suppressed OGD/R-induced M1 polarization, pro-inflammatory cytokine expression, and ROS accumulation, and inhibited activation of the STING-NF-κB signaling pathway. Additionally, Rg1 attenuated early renal fibrosis post-IRI.

Conclusion

Rg1 exerts dual protective effects against renal IRI by reducing oxidative stress and restraining macrophage-mediated inflammation. These findings highlight Rg1 as a promising therapeutic candidate for ischemic kidney injury.

Schlagwörter

Stichwörter der Autor:innen

Ginsenoside Rg1STING-NF-κB pathwayacute kidney injurymacrophage polarizationrenal fibrosisrenal ischemia-reperfusion injury

Autor:innen und Institutionen

  • Department of Urology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, People's Republic of China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Army Medical University, Army Hepatobiliary Surgery Research Institute, Chongqing, 400038, People's Republic of China.

ORCID-Profile: Yi Zhi

Zitieren

APA

Huang, Y., Su, D., You, J., Zhang, Y., Li, Z., Liu, H., Fang, Q., Zhi, Y., & Li, W. (2026). Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation. Journal of Inflammation Research, Volume 19, 1-18. https://doi.org/10.2147/jir.s574702

Vancouver

Huang Y, Su D, You J, Zhang Y, Li Z, Liu H, et al. Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation. Journal of Inflammation Research. 2026;Volume 19:1-18. doi:10.2147/jir.s574702

BibTeX
@article{Huang2026,
  author = {Huang, Yuandi and Su, Dexi and You, Jinshan and Zhang, Yu and Li, Zeyu and Liu, Hao and Fang, Qiang and Zhi, Yi and Li, Weibing},
  title = {Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--18},
  doi = {10.2147/jir.s574702}
}
Kostenlos starten →